Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure

Abstract

[1] Maiwall R, Kumar S, Chaudhary AK, Maras J, Wani Z, Kumar C, et al. Serum ferritin predicts early mortality in patients with decompensated cirrhosis. J Hepatol 2014;61:43–50. [2] Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. CANONIC Study Investigators of the EASL–CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144:1426–1437. [3] Cordoba J, Ventura-Cots M, Simon-Talero M, Amoros A, Pavesi M, Vilstrup H, et al. CANONIC Study Investigators of EASL–CLIF Consortium. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol 2014;60:275–281. [4] Hepner GW, Chopra IJ. Serum thyroid hormone levels in patients with liver disease. Arch Intern Med 1979;139:1117–1120. [5] Guven K, Kelestimur F, Yucesoy M. Thyroid function tests in nonalcoholic cirrhotic patients with hepatic encephalopathy. Eur J Med 1993;2:83–85. [6] Faber J, Thomsen HF, Lumholtz IB, Kirkegaard C, Siersbaek-Nielsen K, Friis T. Kinetic studies of thyroxine, 3,5,30-triiodothyronine, 3,3,50-triiodothyronine, 30 ,50-diiodothyronine, 3,30-diiodothyronine, and 30-monoiodothyronine in patients with liver cirrhosis. J Clin Endocrinol Metab 1981;53:978–984.